Arcturus Therapeutics Holdings Inc. Balance Sheet
ARCT|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$271M
FY2025
Cash
$231M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$214M
FY2025
Arcturus Therapeutics Holdings Inc. had $271M in total assets and $214M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $230.9M | $237.0M | $292.0M | $370.5M | $370.5M | $71.4M | $36.7M |
| Accounts Receivable | $5.6M | $4.0M | $32.1M | $2.8M | $3.4M | $2.1M | $2.2M |
| Current Assets | $241.4M | $306.0M | $386.6M | $403.3M | $379.0M | $467.8M | $74.3M |
| PP&E (Net) | $6.7M | $9.5M | $12.4M | $12.4M | $5.6M | $3.4M | $2.3M |
| Total Assets | $271.1M | $344.1M | $429.4M | $450.4M | $392.8M | $476.5M | $82.1M |
| Current Liabilities | $36.4M | $65.5M | $82.0M | $127.0M | $99.5M | $49.5M | $21.3M |
| Total Debt | - | - | - | - | $15.3M | $13.8M | $15.0M |
| Shareholders' Equity | $214.0M | $241.0M | $278.5M | $396.6M | $228.2M | $13.6M | $33.8M |